Systein Ultra, eye drops 15 ml

Sistain Ultra is a product for moisturizing the corneal surface and increasing eye comfort.

Based on a unique intelligent polymer system, Systain Ultra provides long-lasting protection.

Continued protection also means longer lasting eye comfort. Systein Ultra provides temporary symptom relief.

Indications

Sistain Ultra eye drops can be used to relieve symptoms of eye irritation and discomfort caused by dust, dry air conditioning, smoke, decorative cosmetics, bright sunlight, as well as “dry eye syndrome” or as a result of hours of computer work.

Active ingredient

Composition

An ophthalmic remedy containing 0.001% Polyquad (polydronium chloride);

0.4% polyethylene glycol;

0.7% boric acid;

0.12% potassium chloride;

0.1% sodium chloride;

0.3% propylene glycol;

1.4% sorbitol;

hydroxypropylguar;

0.57% 2-amino-2-methylpropanol,

Hydrochloric acid and/or sodium hydroxide (to adjust the pH), purified water (up to 100% volume).

How to take, the dosage

Shake the bottle before use!

The Systein Moisturizing Eye Drops are to be put in 1-2 drops in each eye as needed, one to several times a day.

If you wear contact lenses, if you have minor irritation, discomfort or clouding, put 1-2 drops in each eye and blink 2-3 times.

Can be used before and during contact lenses, as well as after they are removed.

Special Instructions

Follow the recommendations of your ophthalmologist and the directions for use.

Please consult your doctor if discomfort, tearing, vision changes, or red eyes persist.

Do not touch the tip of the dropper bottle as this may contaminate the solution.

Contraindications

Individual hypersensitivity to the components of the drug.

Pregnancy use

Safety and efficacy of use during pregnancy and lactation have not been studied.

Possible to use during pregnancy and lactation by prescription if the expected effect exceeds the risk of possible side effects.

The use in children under 18 years of age is not recommended because the safety and effectiveness in children has not been established.

Similarities